Insmed Inc (NASDAQ: INSM) is 131.33% higher on its value in year-to-date trading and has touched a low of $21.92 and a high of $80.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INSM stock was last observed hovering at around $72.86 in the last trading session, with the day’s loss setting it -1.17%.
Currently trading at $71.69, the stock is -0.50% and -1.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -1.61% at the moment leaves the stock 37.49% off its SMA200. INSM registered 193.81% gain for a year compared to 6-month gain of 171.76%. The firm has a 50-day simple moving average (SMA 50) of $72.6626 and a 200-day simple moving average (SMA200) of $51.9219.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.47% loss in the last 1 month and extending the period to 3 months gives it a -3.10%, and is 6.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.73% over the week and 3.11% over the month.
Insmed Inc (INSM) has around 912 employees, a market worth around $12.83B and $342.96M in sales. Profit margin for the company is -252.01%. Distance from 52-week low is 227.05% and -10.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.93%).
The EPS is expected to grow by 0.19% this year
522.0 institutions hold shares in Insmed Inc (INSM), with institutional investors hold 109.19% of the company’s shares. The shares outstanding are 178.90M, and float is at 174.74M with Short Float at 7.84%. Institutions hold 108.19% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.01 million shares valued at $1.07 billion. The investor’s holdings represent 10.7864 of the INSM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.26 million shares valued at $955.72 million to account for 9.6086 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 12.16 million shares representing 8.1932 and valued at over $814.95 million, while FMR LLC holds 4.9207 of the shares totaling 7.31 million with a market value of $489.44 million.
Insmed Inc (INSM) Insider Activity
The most recent transaction is an insider sale by Smith Michael Alexander, the company’s Chief Legal Officer. SEC filings show that Smith Michael Alexander sold 27,871 shares of the company’s common stock on Sep 13 ’24 at a price of $74.35 per share for a total of $2.07 million. Following the sale, the insider now owns 67856.0 shares.
Insmed Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Flammer Martina M.D. (Chief Medical Officer) sold a total of 26,969 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $74.90 per share for $2.02 million. Following the transaction, the insider now directly holds 0.11 million shares of the INSM stock.
Still, SEC filings show that on Sep 16 ’24, Flammer Martina M.D. (Chief Medical Officer) disposed off 13,436 shares at an average price of $74.92 for $1.01 million. The insider now directly holds 106,134 shares of Insmed Inc (INSM).
